Publications by authors named "Frances Wj Beck"
Exp Hematol Oncol
May 2015
Article Synopsis
- The combination of rituximab and 2-CdA shows promise as an effective therapy for B-cell tumors, with 75% of evaluated patients responding positively.
- Research conducted on patient samples and animal models reveals enhanced tumor response, particularly in follicular lymphoma, with significant survival benefits noted post-treatment.
- Molecular analysis indicates that the combination triggers important cellular pathways, including the activation of specific kinases, contributing to the therapeutic efficacy.
